Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XW003 Injection in Adult Type 2 Diabetes Mellitus
CTR20211014Phase 2Completed
- Sponsor
- Sciwind Biosciences
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ecnoglutide in type 2 diabetes mellitus (T2DM), sponsored by Sciwind Biosciences. Started May 2021; status: completed.
02
Drugs
ecnoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20211014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211014.